BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11729635)

  • 1. [PPAR gamma agonist and antagonist].
    Kadowaki T
    Nihon Yakurigaku Zasshi; 2001 Nov; 118(5):321-6. PubMed ID: 11729635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
    Yamauchi T; Waki H; Kamon J; Murakami K; Motojima K; Komeda K; Miki H; Kubota N; Terauchi Y; Tsuchida A; Tsuboyama-Kasaoka N; Yamauchi N; Ide T; Hori W; Kato S; Fukayama M; Akanuma Y; Ezaki O; Itai A; Nagai R; Kimura S; Tobe K; Kagechika H; Shudo K; Kadowaki T
    J Clin Invest; 2001 Oct; 108(7):1001-13. PubMed ID: 11581301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The molecular mechanisms by which PPAR gamma/RXR inhibitors improve insulin resistance].
    Yamauchi T; Kadowaki T
    Nihon Rinsho; 2001 Nov; 59(11):2245-54. PubMed ID: 11712415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance.
    Yamauchi T; Kamon J; Waki H; Murakami K; Motojima K; Komeda K; Ide T; Kubota N; Terauchi Y; Tobe K; Miki H; Tsuchida A; Akanuma Y; Nagai R; Kimura S; Kadowaki T
    J Biol Chem; 2001 Nov; 276(44):41245-54. PubMed ID: 11533050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.
    Kubota N; Terauchi Y; Miki H; Tamemoto H; Yamauchi T; Komeda K; Satoh S; Nakano R; Ishii C; Sugiyama T; Eto K; Tsubamoto Y; Okuno A; Murakami K; Sekihara H; Hasegawa G; Naito M; Toyoshima Y; Tanaka S; Shiota K; Kitamura T; Fujita T; Ezaki O; Aizawa S; Kadowaki T
    Mol Cell; 1999 Oct; 4(4):597-609. PubMed ID: 10549291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet.
    Matsui J; Terauchi Y; Kubota N; Takamoto I; Eto K; Yamashita T; Komeda K; Yamauchi T; Kamon J; Kita S; Noda M; Kadowaki T
    Diabetes; 2004 Nov; 53(11):2844-54. PubMed ID: 15504964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
    Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W
    Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR gamma/RXR as a molecular target for diabetes.
    Lenhard JM
    Recept Channels; 2001; 7(4):249-58. PubMed ID: 11697231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
    Vidal-Puig A; Jimenez-LiƱan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE
    J Clin Invest; 1996 Jun; 97(11):2553-61. PubMed ID: 8647948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
    Singh Ahuja H; Liu S; Crombie DL; Boehm M; Leibowitz MD; Heyman RA; Depre C; Nagy L; Tontonoz P; Davies PJ
    Mol Pharmacol; 2001 Apr; 59(4):765-73. PubMed ID: 11259621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation.
    Koh EH; Kim MS; Park JY; Kim HS; Youn JY; Park HS; Youn JH; Lee KU
    Diabetes; 2003 Sep; 52(9):2331-7. PubMed ID: 12941773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.
    He W; Barak Y; Hevener A; Olson P; Liao D; Le J; Nelson M; Ong E; Olefsky JM; Evans RM
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15712-7. PubMed ID: 14660788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
    Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
    Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice.
    Fukui Y; Masui S; Osada S; Umesono K; Motojima K
    Diabetes; 2000 May; 49(5):759-67. PubMed ID: 10905484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues.
    Way JM; Harrington WW; Brown KK; Gottschalk WK; Sundseth SS; Mansfield TA; Ramachandran RK; Willson TM; Kliewer SA
    Endocrinology; 2001 Mar; 142(3):1269-77. PubMed ID: 11181544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.
    Cha BS; Ciaraldi TP; Carter L; Nikoulina SE; Mudaliar S; Mukherjee R; Paterniti JR; Henry RR
    Diabetologia; 2001 Apr; 44(4):444-52. PubMed ID: 11357475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors.
    Iwaki M; Matsuda M; Maeda N; Funahashi T; Matsuzawa Y; Makishima M; Shimomura I
    Diabetes; 2003 Jul; 52(7):1655-63. PubMed ID: 12829629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
    Murakami K; Tobe K; Ide T; Mochizuki T; Ohashi M; Akanuma Y; Yazaki Y; Kadowaki T
    Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.